everyone. and you, Thank good Michael, morning,
our to are been get moment unprecedented Before the the I challenges take facing times caregivers gratitude and to providers front and These our into those like a would performance, I health unexpected monumental. to have of pandemic. the care lines express this on
I would the to out in our behind our their They essential with busy fulfilling mission each other, the thank I'm has working way our and a this factories, the and and crisis, caregivers world. those field together and healthier team with create also those our to those services. own scenes to helping homes. impressed like during are customers come people, support offices from our labs, in working increasingly safer products and
we to long-term STERIS, clear, have approach At business. a running the
are this and If last we pandemic well closely our our above-average groups, and it confident This decade deliver philosophy successfully for first has believe, through will will the are over we those as see do come customers well. through jobs two us several to by guided we plus, people. Our significant returns followed our us challenges we shareholders.
on to areas for We biologics. be we focus believe care, what strategy growth have vaccines, health chosen to in procedures, a
to balance While we in nature, we our procedures, revenue. be in to to believe downturn are we business recurring and capital have equipment of exposure good terms in of and not these temporary developed the areas mix to which immune a a nice
and a and to been delivery supply decade, protect for more on-shoring have have quality, service lean better Finally, than we employed our product in-sourcing cost. reliability improving techniques and and chains
a As a we've result, long-term had run. positive
our in has economy. significant far, disruption fared well the the so comparatively amidst global business And
this is say completed, safe to pandemic. For phenomenal, the it XXXX, were year fiscal celebrating we record-breaking not for just we be would it
the revenue S&P profitability, a very of very puts been year first enviable solid forward challenges with the We had another to rates have the in ended XXXX. repeat and an growth broke strong the face balance today. sheet $X time, mark in record and and the year billion looking to position strong growth XXX, revenue joined would before in This us performance fiscal for us
a constant we've investments on health all tuck-in made benefit mostly the currency basis XXX and as acquisitions organic This all basis in products. solid X% XX% performance XXXX small of a as in grew as with across in well our points growth Revenue approximately fiscal from result was businesses care of reported segments.
led Our pack, organic constant growing XX% year. AST currency the the revenue for segment
we've pharma We beyond. year, medical setting, personal segment customers. gowns As demand and and for strong like continued devices our has PPE AST and will medical in in fiscal experienced those our continue the this insulin use glucose like for gloves be from this device facilities the run, process XXXX blood for pumps and currently growth in long monitors. plan see that and in for home discussed Demand investing business increased core in to all view, we
see like devices implants. begun We to in declines have, procedure-related time-deferrable however, orthopedic
had this outstanding as revenue a again. year, organic providers begin year. despite constant currency health expect comparisons doing growing relatively be We to procedures Specialty difficult with prior short-term Services these Healthcare XX%, phenomenon the another care
to their see our our impact outsourced maintenance U.S. in decline offerings insulated comprehensive impacted in more by was fourth has Specific the success across of our instruments. COVID-XX, We of of of instrument as while repair our business for downtime procedures, advantage of a the the took relatively spectrum to continue quarter, reprocessing business been customers many
the so or due a across you procedures expect, decline to reduction America. last As March in in significant saw year-over-year into of and nonessential week we the might April,
COVID-XX. in but business constant had organic currency full on XXXX, followed sales Sciences than anticipated, lumpy this cadence typical better exceeded basis. growth to Life growing in fourth growth high Capital least, upward year due In single a consumables, fiscal year partially at a was XX%, spike revenue an to the a we our double-digit year expectations. equipment our quarter, which low with saw XX% all in
in But stocked level to have growth to to to XX% appear growth return expect for orders in customers coming Science our up, strong pharma a We've our continued Life resulting more fourth of we normalized quarter months. the Some in in consumables. see April.
challenging currency franchise. had And growth new year consumables finally, our and continues comparisons capital with infection revenue particularly constant growth from X% Organic Healthcare to to Products XXXX. prevention stem strong also organic in equipment products, fiscal against a
from which I XXX revenue products. acquisitions to added significant the a COVID-XX earlier, experienced growth. is annual the Products endoscopy pandemic, points dozen approximately Healthcare addition, the particularly loss or most from basis segment this the mentioned most with tuck-in acquisitions, In year, this Offsetting in as so impact our half immediate
volume the XXXX and increased fiscal positive over combined represent of gross our segment. for to XX.X%, end impact reflecting offset less share per points full improved this fiscal record acquisitions, STERIS COVID-related and of expectations high basis other total $X.XX, quarter, reductions each margin the fourth in in Adjusted growth a for diluted expansion. XX essentially earnings recent the Adjusted XX% For to were year operating XXXX. the margins the
us solid well with results, which, We addition these sheet, are future. pleased balance the position for to very our in
of procedures, fluid, at business making high-end remains care are impact As the are on we X% or we for this impact offset COVID-XX demand. of XXXX. by daunting severity are from in will many health linked the fiscal X% revenue impacted that you've pandemic, to depend of the for STERIS rates the others, to the Where our of of time. The profit experiencing growth COVID-XX have not would pullback areas heard and our been revenue and comfortable not increased traditional the forecasting confident of at
quantitative of to year and will the views guidance qualitative share we progresses. guidance, lieu In revisit as our expect
a is fiscal Great across provider pharma is we customers, as the during device, X%. that our We will Recession XXXX, it be XXXX, in Even was business which, healthcare decline months coming source of year of revenue the strength and fortunate are believe, our as diversified our and medical quarters. worst
decline that our revenue the we period Great about care decline year. uncertainty be X% during Recession, was fiscal quarters and we had years. contained at three impact different downturn. And worst declined at beginning of economic XXXX, may the calendar This look happened our recall, four few health Obamacare you spending That that other the going with for If spread time. it in revenue consecutive things of of on the over combined a to the quarters
capital time we than at that The was equipment in that today. of more we are equipment, capital heavy preponderance and decline were
In earlier, Healthcare of mentioned performance Life business, somewhat March, in from offset well and I AST. declines our experienced so fared to we relatively As positive our far. by month businesses modest neutral the Science
XXXX In positive Science versus April, AST. XX% return total for This and performance Life beginning Healthcare of with to than again stronger less are April we of On in resulted deposit STERIS note, decline a April procedures. revenue in see a in we XXXX. saw neutral a declines
gradual and are calendar Similar possibly to end While we levels sooner. we this we of expect anticipate back to early in our this encouraged space, ramping by up the are the leaders. on, be year by discussions having hospital others with we return more normalized to
ready to start Given will or back expectation are that so, volumes our customer in up people standby to meet financial procedure our quarter underutilized strength coming ramp the needs. on our and
not We paid are have short-term instituted although furloughs. on layoffs, some
available as point, full-time they paid At to not is ramp they for wage every will hours, up normal or are We procedures are this regular people work full salary the our support one do or time. thing right at as of as to working levels. help long this they this our normal us being time their whether customers and basic their working to is believe
we We and to organization, have skilled highly skill set. that and and committed maintain grow in our people want
will to continue normal be until week-by-week we're more and levels, business as resumes able appropriate. adjust hope taking We to position this to it but
canceling our capital. some increases, a significant freeze hiring for routine slowdown. include travel to for growth events, protect deferring expenditures near-term most restricting We implementing from have capital These actions cash travel positions, executive strategic except deferring flow the wage and taken
part, most are customers. service the running been our have operations and our support and For plants to
are We some of and facilities limited below have operating shutdowns capacity. had normal some
our levels at particularly strategic continue intend to reprocessing. We continue R&D AST to normal growth in spending, in and outsourced capital invest and
that We continue intermediate believe longer-term. pay will in off these to and the investments
strength mentioned, of sheet Mike our strong As a remains company. balance the
priorities allocation We dividends in anticipated unchanged. paying future remain drive to to growth. plan and our continue to capital Our invest businesses
even become those Our evaluate buybacks near-term but discontinued lastly, opportunities. more for the been to expectations, and share deferred visibility of to M&A And compensation. for offset activities selective executive continue dilution lack have for we have now, due to
essential As care. business health know, an supporting is STERIS you
fortunate and be the a in in strong very are our be to procedures and We nimble to business support we're customers financial be position. as in We ready to to restart. clinical need
disinfect provide health to on this crisis. be We front pleased with able care to relief during solutions to some very lines the hospital respirators are
support. balance STERIS we continue of of to We thank the longer-term the We as enhance value working and company long-term you the opportunities. continued with our impacts is the all bright, your short-term your for future believe of pandemic for
Q&A. turn will Julie to over I call now the for back